Agilent Q3 Earnings Beat Estimates, Revenues Up Y/Y, Shares Rise

Agilent Technologies (A) reported robust fiscal Q3 2025 results, with earnings per share of $1.37 and revenues of $1.74 billion, both surpassing consensus estimates and marking year-over-year increases of 3.8% and 10.1% respectively, driven by growth across all segments. Shares rose 3.3% on the news, reflecting positive investor sentiment despite observed contractions in operating margins across its segments. The company also provided an optimistic outlook, guiding for Q4 revenues of $1.822-$1.842 billion and projecting fiscal 2025 revenues between $6.91-$6.93 billion with EPS of $5.56-$5.59.

Analysis

Agilent Technologies reported a strong fiscal third quarter, beating consensus estimates on both revenue and earnings. Revenue grew 10.1% year-over-year to $1.74 billion, fueled by broad-based growth across its Life Sciences and Diagnostics (LDG), Agilent CrossLab (ACG), and Applied Markets (AMG) segments. The top-line beat and a 3.8% YoY increase in EPS to $1.37 prompted a 3.3% rise in the company's shares. However, this top-line strength is contrasted by significant profitability pressures. The company's non-GAAP operating margin contracted by 220 basis points year-over-year to 25.1%, with gross margin declines observed in every segment, most notably a 390 basis point contraction in the LDG unit. While the company has reduced R&D spending as a percentage of revenue, this was insufficient to prevent margin erosion. Despite these margin headwinds, management provided an optimistic outlook for Q4 and the full fiscal year 2025, projecting continued revenue growth of up to 8.3% for the next quarter and full-year EPS between $5.56 and $5.59, which appears to be sustaining investor confidence for now.

Key Decisions for Investors

• Investors should weigh the robust revenue growth and positive forward guidance against the significant and broad-based contraction in operating and gross margins, which presents the primary risk to the investment thesis.
• Closely scrutinize future earnings reports for any stabilization or improvement in profitability, as sustained margin pressure could erode the benefits of the strong top-line performance.
• Consider that while the earnings beat triggered a positive stock reaction, the stock's 8.4% year-to-date decline still underperforms its sector, suggesting the market may remain cautious until margin concerns are addressed.